Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $DFTX vs $MANE | Chartloom

Compare

$DFTX vs $MANE

Definium Therapeutics Inc · Veradermics Inc

DFTX

Definium Therapeutics Inc

MANE

Veradermics Inc

Compare $DFTX vs $MANE

Comparing Definium Therapeutics Inc and Veradermics Inc

DFTXDefinium Therapeutics Inc

MANEVeradermics Inc

DFTXDefinium Therapeutics Inc

Market cap

$4.28B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

152.1%

52W performance

191.1%

FCF yield

-3.9%

MANEVeradermics Inc

Market cap

$4.86B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

208.0%

52W performance

208.0%

FCF yield

-2.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DFTX

MANE

Detailed metrics comparison

DFTX

Definium Therapeutics Inc

MANE

Veradermics Inc

Market Cap

DFTX$4.28B

MANE$4.86B

Enterprise Value

DFTX$3.67B

MANE$4.54B

Price

DFTX$34.38

MANE$116.26

P/E Ratio

DFTXN/A

MANEN/A

P/S Ratio

DFTX0.00x

MANE0.00x

EV/Sales

DFTX0.00x

MANE0.00x

EV/EBITDA

DFTX0.00x

MANE0.00x

P/B Ratio

DFTX5.40x

MANE6.72x

P/FCF Ratio

DFTXN/A

MANEN/A

EV/FCF

DFTX-21.83x

MANE-42.29x

PEG Ratio

DFTXN/A

MANEN/A

Forward P/E (NTM)

DFTXN/A

MANEN/A

Forward P/S (NTM)

DFTXN/A

MANEN/A

Revenue (TTM)

DFTX$0

MANE$0

Revenue Growth (YoY)

DFTXN/A

MANEN/A

Forward Rev Growth

DFTX717.7%

MANE308.7%

Gross Margin (TTM)

DFTX0.0%

MANE0.0%

Operating Margin (TTM)

DFTX0.0%

MANE0.0%

EBITDA Margin (TTM)

DFTX0.0%

MANE0.0%

Net Margin (TTM)

DFTX0.0%

MANE0.0%

FCF Margin (TTM)

DFTXN/A

MANEN/A

Net Income (TTM)

DFTX$-354M

MANE$-137M

FCF (TTM)

DFTX$-168M

MANE$-107M

EPS (TTM)

DFTX-$3.20

MANE-$3.39

ROE (TTM)

DFTX-8523.0%

MANE-3549.0%

ROA (TTM)

DFTX-6458.0%

MANE-3463.0%

ROIC (TTM)

DFTX-7781.0%

MANE-3549.0%

Cash

DFTX$655M

MANE$319M

Debt

DFTX$36M

MANE$0

Net Cash/Debt

DFTX$619M

MANE$319M

Current Ratio (TTM)

DFTX6.95x

MANE70.53x

Quick Ratio (TTM)

DFTX6.89x

MANE70.35x

Debt/Equity (TTM)

DFTX0.04x

MANE0.00x

Debt/Assets (TTM)

DFTX0.0%

MANE0.0%

Interest Coverage (TTM)

DFTXN/A

MANEN/A

Net Debt/EBITDA (TTM)

DFTX0.00x

MANE0.00x

Beta

DFTX2.23

MANE-0.05

52W Performance

DFTX191.1%

MANE208.0%

YTD Performance

DFTX152.1%

MANE208.0%

% from 52W High

DFTX-30.8%

MANE-15.0%

% from 52W Low

DFTX228.5%

MANE263.3%

Asset Turnover (TTM)

DFTX0.00x

MANE0.00x

FCF Yield (TTM)

DFTX-3.9%

MANE-2.2%

Earnings Yield (TTM)

DFTX-8.3%

MANE-2.8%

Dividend Yield (TTM)

DFTXN/A

MANEN/A

Rule of 40

DFTX0.0

MANE0.0

EV/GP/RG

DFTXN/A

MANEN/A

Ticker research

View DFTX research View MANE research

Metric	DFTX Definium Therapeutics Inc	MANE Veradermics Inc
Market & Valuation
Market Cap	$4.28B	$4.86B
Enterprise Value	$3.67B	$4.54B
Price	$34.38	$116.26
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	5.40x	6.72x
P/FCF Ratio	N/A	N/A
EV/FCF	-21.83x	-42.29x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	717.7%	308.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-354M	$-137M
FCF (TTM)	$-168M	$-107M
EPS (TTM)	-$3.20	-$3.39
ROE (TTM)	-8523.0%	-3549.0%
ROA (TTM)	-6458.0%	-3463.0%
ROIC (TTM)	-7781.0%	-3549.0%
Financial Health
Cash	$655M	$319M
Debt	$36M	$0
Net Cash/Debt	$619M	$319M
Current Ratio (TTM)	6.95x	70.53x
Quick Ratio (TTM)	6.89x	70.35x
Debt/Equity (TTM)	0.04x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.23	-0.05
52W Performance	191.1%	208.0%
YTD Performance	152.1%	208.0%
% from 52W High	-30.8%	-15.0%
% from 52W Low	228.5%	263.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-3.9%	-2.2%
Earnings Yield (TTM)	-8.3%	-2.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View DFTX research	View MANE research

Valuation

P/S Ratio

DFTX

0.00x

MANE

0.00x

EV/FCF

MANE

-42.29x

DFTX

-21.83x

Growth & revenue

Forward Revenue Growth

DFTX

717.7%

MANE

308.7%

Profitability & performance

Gross Margin

DFTX

0.0%

MANE

0.0%

ROE

MANE

-3549.0%

DFTX

-8523.0%

FCF Yield %

MANE

-2.2%

DFTX

-3.9%

52-Week Performance

MANE

208.0%

DFTX

191.1%

Detailed metrics comparison

DFTX

Definium Therapeutics Inc

MANE

Veradermics Inc

Market Cap

DFTX$4.28B

MANE$4.86B

Enterprise Value

DFTX$3.67B

MANE$4.54B

Price

DFTX$34.38

MANE$116.26

P/E Ratio

DFTXN/A

MANEN/A

P/S Ratio

DFTX0.00x

MANE0.00x

EV/Sales

DFTX0.00x

MANE0.00x

EV/EBITDA

DFTX0.00x

MANE0.00x

P/B Ratio

DFTX5.40x

MANE6.72x

P/FCF Ratio

DFTXN/A

MANEN/A

EV/FCF

DFTX-21.83x

MANE-42.29x

PEG Ratio

DFTXN/A

MANEN/A

Forward P/E (NTM)

DFTXN/A

MANEN/A

Forward P/S (NTM)

DFTXN/A

MANEN/A

Revenue (TTM)

DFTX$0

MANE$0

Revenue Growth (YoY)

DFTXN/A

MANEN/A

Forward Rev Growth

DFTX717.7%

MANE308.7%

Gross Margin (TTM)

DFTX0.0%

MANE0.0%

Operating Margin (TTM)

DFTX0.0%

MANE0.0%

EBITDA Margin (TTM)

DFTX0.0%

MANE0.0%

Net Margin (TTM)

DFTX0.0%

MANE0.0%

FCF Margin (TTM)

DFTXN/A

MANEN/A

Net Income (TTM)

DFTX$-354M

MANE$-137M

FCF (TTM)

DFTX$-168M

MANE$-107M

EPS (TTM)

DFTX-$3.20

MANE-$3.39

ROE (TTM)

DFTX-8523.0%

MANE-3549.0%

ROA (TTM)

DFTX-6458.0%

MANE-3463.0%

ROIC (TTM)

DFTX-7781.0%

MANE-3549.0%

Cash

DFTX$655M

MANE$319M

Debt

DFTX$36M

MANE$0

Net Cash/Debt

DFTX$619M

MANE$319M

Current Ratio (TTM)

DFTX6.95x

MANE70.53x

Quick Ratio (TTM)

DFTX6.89x

MANE70.35x

Debt/Equity (TTM)

DFTX0.04x

MANE0.00x

Debt/Assets (TTM)

DFTX0.0%

MANE0.0%

Interest Coverage (TTM)

DFTXN/A

MANEN/A

Net Debt/EBITDA (TTM)

DFTX0.00x

MANE0.00x

Beta

DFTX2.23

MANE-0.05

52W Performance

DFTX191.1%

MANE208.0%

YTD Performance

DFTX152.1%

MANE208.0%

% from 52W High

DFTX-30.8%

MANE-15.0%

% from 52W Low

DFTX228.5%

MANE263.3%

Asset Turnover (TTM)

DFTX0.00x

MANE0.00x

FCF Yield (TTM)

DFTX-3.9%

MANE-2.2%

Earnings Yield (TTM)

DFTX-8.3%

MANE-2.8%

Dividend Yield (TTM)

DFTXN/A

MANEN/A

Rule of 40

DFTX0.0

MANE0.0

EV/GP/RG

DFTXN/A

MANEN/A

Ticker research

View DFTX research View MANE research

Metric	DFTX Definium Therapeutics Inc	MANE Veradermics Inc
Market & Valuation
Market Cap	$4.28B	$4.86B
Enterprise Value	$3.67B	$4.54B
Price	$34.38	$116.26
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	5.40x	6.72x
P/FCF Ratio	N/A	N/A
EV/FCF	-21.83x	-42.29x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	717.7%	308.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-354M	$-137M
FCF (TTM)	$-168M	$-107M
EPS (TTM)	-$3.20	-$3.39
ROE (TTM)	-8523.0%	-3549.0%
ROA (TTM)	-6458.0%	-3463.0%
ROIC (TTM)	-7781.0%	-3549.0%
Financial Health
Cash	$655M	$319M
Debt	$36M	$0
Net Cash/Debt	$619M	$319M
Current Ratio (TTM)	6.95x	70.53x
Quick Ratio (TTM)	6.89x	70.35x
Debt/Equity (TTM)	0.04x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.23	-0.05
52W Performance	191.1%	208.0%
YTD Performance	152.1%	208.0%
% from 52W High	-30.8%	-15.0%
% from 52W Low	228.5%	263.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-3.9%	-2.2%
Earnings Yield (TTM)	-8.3%	-2.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View DFTX research	View MANE research